Ganglioneuroma differential diagnosis

Revision as of 16:07, 12 September 2012 by Kalsang Dolma (talk | contribs)
Jump to navigation Jump to search

Ganglioneuroma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ganglioneuroma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ganglioneuroma differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ganglioneuroma differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ganglioneuroma differential diagnosis

CDC on Ganglioneuroma differential diagnosis

Ganglioneuroma differential diagnosis in the news

Blogs on Ganglioneuroma differential diagnosis

Directions to Hospitals Treating Ganglioneuroma

Risk calculators and risk factors for Ganglioneuroma differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Differentiating Ganglioneuroma from other Diseases

  • Ganglioneuromas are rare tumors that most frequently start in the autonomic nerve cells, which may be in any part of the body. The tumor are usually noncancerous (benign).
  • Ganglioneuromas usually occur in people ages 10 to 40. They grow slowly, and may release certain chemicals or hormones.

References


Template:WikiDoc Sources